-
without the need for additional invasive measurements. The research is embedded within the Quantitative Healthcare Analysis (qurAI) group and conducted in close collaboration with the CARA Lab and clinical
-
embedded within the Quantitative Healthcare Analysis (qurAI) group and conducted in close collaboration with the CARA Lab and clinical partners in the Netherlands and abroad. You will work with large, multi
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
megalencephalic leukoencephalopathy with subcortical cysts (MLC). The project combines behavioural and neurological phenotyping with the development of an automated EEG analysis pipeline. You will use
-
therapies; cross-border access and reimbursement pathways for innovative therapies in Europe. You will use a combination of regulatory document analysis, expert interviews and case studies. This will allow
-
MRI, high-resolution confocal microscopy and electron microscopy. Develop and refine imaging analysis pipelines, using appropriate software, quantitative approaches and innovative analytical methods
-
engagement. You will have the opportunity to shape the focus of your research according to your background and interests, with an emphasis either on iPSC-based disease modelling or on computational analysis
-
of quality-of-life measures, analysis of risk and resilience factors, and longitudinal research into patient and family outcomes. You will collaborate with clinicians, psychologists, methodologists, patient
-
background and interests, with an emphasis either on iPSC-based disease modelling or on computational analysis and integration of multi-omics data.